Advertisement
Screener

Nuvation Bio Inc. (NUVB) Other

Nuvation Bio Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-02: Form 10-K; Item Shares outstanding CommonClassA as of 2026-02-26; As filed 346,597,289.
  • 2026-03-02: Form 10-K; Item Shares outstanding CommonClassB as of 2026-02-26; As filed 1,000,000.
  • 2025-11-03: Form 10-Q; Item Stock registered under Section 12(b); As filed Class A Common Stock, $0.0001 par value per share · NUVB · NYSE.
  • 2025-11-03: Form 10-Q; Item Stock registered under Section 12(b); As filed Redeemable Warrants, each whole warrantexercisable for one share of Class A Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE.
FiledFormItemAs filed
2026-03-0210-KShares outstanding CommonClassA as of 2026-02-26346,597,289
2026-03-0210-KShares outstanding CommonClassB as of 2026-02-261,000,000
2025-11-0310-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2025-11-0310-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Class A Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2025-08-0710-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2025-08-0710-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Class A Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2025-05-0710-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2025-05-0710-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2025-03-0610-KShares outstanding CommonClassA as of 2025-02-28337,678,855
2025-03-0610-KShares outstanding CommonClassB as of 2025-02-281,000,000
2025-03-0610-KStock registered under Section 12(b)Warrants to Purchase Class A Common Stock · NUVB.WS · NYSE
2024-11-0610-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2024-11-0610-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2024-08-0510-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2024-08-0510-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2024-05-1410-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2024-05-1410-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2024-04-2610-K/AShares outstanding CommonClassA as of 2024-02-16218,046,219
2024-04-2610-K/AShares outstanding CommonClassB as of 2024-02-161,000,000
2024-04-2610-K/AStock registered under Section 12(b)Warrants to Purchase Class A Common Stock · NUVB.WS · NYSE
2024-02-2910-KShares outstanding CommonClassA as of 2024-02-16218,046,219
2024-02-2910-KShares outstanding CommonClassB as of 2024-02-161,000,000
2024-02-2910-KStock registered under Section 12(b)Warrants to Purchase Class A Common Stock · NUVB.WS · NYSE
2023-11-0210-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2023-11-0210-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2023-08-0310-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2023-08-0310-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2023-05-0410-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2023-05-0410-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2023-03-1510-KShares outstanding CommonClassA as of 2023-02-17217,803,722
2023-03-1510-KShares outstanding CommonClassB as of 2023-02-171,000,000
2023-03-1510-KStock registered under Section 12(b)Warrants to Purchase Class A Common Stock · NUVB.WS · NYSE
2022-11-0310-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2022-11-0310-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2022-11-0310-QSmaller reporting companyNo
2022-08-0410-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2022-08-0410-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2022-08-0410-QSmaller reporting companyNo
2022-05-0910-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2022-05-0910-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2022-05-0910-QSmaller reporting companyNo
2022-02-2810-KShares outstanding CommonClassA as of 2022-02-18218,059,125
2022-02-2810-KShares outstanding CommonClassB as of 2022-02-181,000,000
2022-02-2810-KStock registered under Section 12(b)Warrants to Purchase Class A Common Stock · NUVB.WS · NYSE
2021-11-1010-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2021-11-1010-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2021-11-1010-QEmerging growth companyYes
2021-08-1210-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2021-08-1210-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2021-08-1210-QEmerging growth companyYes
2021-05-2110-K/AStock registered under Section 12(b)Warrants to Purchase Class A Common Stock · NUVB.WS · NYSE
2021-05-2110-K/AEmerging growth companyYes
2021-05-1710-QStock registered under Section 12(b)Class A Common Stock, $0.0001 par value per share · NUVB · NYSE
2021-05-1710-QStock registered under Section 12(b)Redeemable Warrants, each whole warrantexercisable for one share of Common Stock at anexercise price of $11.50 per share · NUVB.WS · NYSE
2021-05-1710-QEmerging growth companyYes
2021-03-1110-KStock registered under Section 12(b)Warrants to Purchase Class A Common Stock · NUVB.WS · NYSE
2021-03-1110-KEmerging growth companyYes
2020-11-1610-QShell companyYes
2020-11-1610-QEmerging growth companyYes
2020-11-1610-QCurrent in its reportingNo
2020-08-1410-QShell companyYes
2020-08-1410-QEmerging growth companyYes
2020-08-1410-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Biohaven Ltd. (BHVN)United States$1.990B-3.83
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Generate Biomedicines, Inc. (GENB)United States$2.052B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B